LDN-193189: Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase Added details of LDN-193189 |
imported>Xenbase |
||
| Line 3: | Line 3: | ||
==Alternative names== | ==Alternative names== | ||
1062368-24-4 | *1062368-24-4 | ||
4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | *4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | ||
CHEMBL513147 | *CHEMBL513147 | ||
UNII-W69H5YQU9O | *UNII-W69H5YQU9O | ||
LDN193189 | *LDN193189 | ||
==Usage Notes== | ==Usage Notes== | ||
Latest revision as of 09:35, 15 January 2021
Description
LDN-193189 is a selective BMP receptor inhibitor that inhibits transcriptional activity of Alk2 and Alk3 BMP type 1 receptors. Also inhibits Smad1, Smad5 and Smad8 activation.
Alternative names
- 1062368-24-4
- 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
- CHEMBL513147
- UNII-W69H5YQU9O
- LDN193189
Usage Notes
References
> 8 Xenbase articles contain a reference to LDN-193189 according to textpresso